Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Modernas rally is being tied to positive Phase 3 results for its personalized melanoma cancer vaccine with Merck, alongside CEO optimism about the broader oncology pipeline and anticipation of detailed trial data at ESMO. Traders are celebrating new highs and speculating about short covering, while skeptics argue that the treatments commercial potential and the stocks valuation remain uncertain.

TeraWulfs sharp pullback is drawing attention despite bullish analyst coverage tied to its shift toward AI/HPC data centers and contracted capacity. Bulls see value in its power and leasing pipeline and point to high short interest, while bears focus on insider transactions, financing and execution risks, and the stocks weakness versus peers.

QNTs sharp rally is being attributed by traders to its Robinhood listing and news of Quants role in tokenized-deposit and asset initiatives with banks. Bulls view the developments as validation of Quants financial-infrastructure use case and point to limited supply, while skeptics question whether institutional adoption will translate into token demand and warn the move could fade.

First Solars sharp selloff and fresh 52-week low are drawing attention amid analyst target cuts and concerns about limited visibility into future bookings, alongside broader solar-sector and trade-policy uncertainty. Traders are divided between calling the drop an oversold buying opportunity and expecting further weakness, with some attributing the move to short-selling or manipulation without evidence.

ONDOs sharp rally has traders discussing a possible technical breakout and renewed interest in its real-world-asset tokenization business, with some attributing the move to DTCC-related developments. Bulls see momentum building, while skeptics question whether the gains can hold and note that the tokens value still depends on a potential fee-sharing mechanism.

Costcos fourth-quarter results beat expectations, but shares barely moved, prompting debate over why the strong report failed to lift the stock. Traders are weighing resilient sales and digital growth against Costcos rich valuation and the temporary boost from tariff refunds to earnings.

T-Mobiles slide to a multi-year low is drawing attention after traders cited a JPMorgan target cut tied to a softer Q3 service-revenue outlook. The community is split between calling the selloff an oversold buying opportunity and expecting further weakness, with competition and merger uncertainty adding to concerns.

CleanSparks disclosed long-term Meta lease for its Georgia AI data center and debt financing for the buildout dominate discussion as traders weigh the companys shift beyond Bitcoin mining. Bulls see contracted AI-infrastructure revenue and rising Bitcoin as upside drivers, while skeptics worry about borrowing costs, execution risk, and the stocks muted response.

Novavaxs C. difficile vaccine candidate is drawing attention after traders discussed positive preclinical results and reported manufacturing preparations ahead of possible clinical development. Some see the update as evidence of progress in the Matrix-M platform, while others remain skeptical about execution and point to speculative oncology-partnership and short-squeeze narratives.

Nokias expanding NVIDIA-powered AI-RAN trials with operators, alongside a UK defense partnership, are driving attention as traders focus on the companys push into AI-network infrastructure and reported efficiency gains. Bulls view the announcements as evidence of commercial momentum, while others remain wary after sharp, volatile swings and question whether the news will translate into sustained gains.